Key facts
- This page summarizes Keith Marchiando's Form 4 filing for Zivo Bioscience, Inc. (ZIVO).
- 4 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 06 Jun 2024, 18:26.
Keith Marchiando - 05 Jun 2024 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ZIVO
- Reported as of
- 05 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Jun 2024, 18:26:45 UTC
- Prior SEC filing
- 31 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Keith Marchiando
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Keith Marchiando filed Form 4 for Zivo Bioscience, Inc. (ZIVO) on 06 Jun 2024.
Change
- Previous filing in this sequence was filed on 31 Aug 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZIVO
transaction
Derivative
Nonstatutory Stock Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -27,083
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 27,083
- Exercise price
- $67.20
- Footnotes
- F1, F2, F3
ZIVO
transaction
Derivative
Nonstatutory Stock Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -48,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 48,000
- Exercise price
- $33.00
- Footnotes
- F1, F3, F4
ZIVO
transaction
Derivative
Nonstatutory Stock Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -10,333
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,333
- Exercise price
- $23.64
- Footnotes
- F1, F3, F5
ZIVO
transaction
Derivative
Nonstatutory Stock Option to Purchase Common Stock
Award
- Transaction value
- Shares
- +444,498
- Change %
- Price
- Shares after
- 444,498
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 444,498
- Exercise price
- $7.96
- Footnotes
- F3, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 80 reverse stock split of the Issuer's stock in May 2021 and a 1 for 6 reverse stock split of the Issuer's stock in October 2023, as applicable.
Footnote F2
The canceled option was fully vested.
Footnote F3
The Issuer canceled options for an aggregate 85,416 shares of the Issuer's common stock granted to the Reporting Person on 1/1/2021, 10/21/2021, and 8/29/2022. In exchange for the canceled options, the Reporting Person received a replacement option, for 444,498 shares, having an exercise price of $7.96.
Footnote F4
The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 10/21/2021 and vested as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.
Footnote F5
The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 8/29/2022 and vested as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.
Footnote F6
The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 328,065 immediately upon grant acceptance, 13,551 on July 1, 2024, 13,442 on August 28, 2024, 62,447 on October 21, 2024, 13,551 on January 1, 2025, and 13,442 on August 28, 2025.